.LOOKING FOR UPDATE FROM THE COMPANY SOON=================HUGE HEADS UP == The Company plans to advance Brilacidin oral rinse into Phase 3 development, subject to available financial resources. Positive results were also observed in a Phase 2 Proof-of-Concept trial treating patients locally with Brilacidin for Ulcerative Proctitis/Ulcerative Proctosigmoiditis Press release content from Globe Newswire. The AP news staff was not involved in its creation. Click to copy RELATED TOPICS apf-health Virus Outbreak Globe Newswire GlobeNewswire: Medical PRESS RELEASE: Paid content from Globe Newswire Innovation Pharmaceuticals Brilacidin Received by U.S. Regional Biocontainment Laboratory; Testing Against Coronavirus (COVID-19) Innovation Pharmaceuticals Inc. March 9, 2020 https://apnews.com/Globe%20Newswire/e8b34337537c7ece88e56b5354afde58U.S. Regional Biocontainment Lab to Begin Testing of Brilacidin Against Coronavirus (COVID-19) Next Week https://www.globenewswire.com/news-release/2020/03/10/1997971/0/en/U-S-Regional-Biocontainment-Lab-to-Begin-Testing-of-Brilacidin-Against-Coronavirus-COVID-19-Next-Week.html